NEW YORK (GenomeWeb) – Immunexpress announced yesterday that it has formed a four-year alliance with the University of Amsterdam's Academic Medical Center (AMC) to characterize and clinically evaluate sepsis-related biomarker signatures of host response.

The partners will specifically evaluate proprietary biomarker signatures, as well as novel RNA, protein, and epigenetic biomarkers, with the goal of advancing Immunexpress' pipeline of host response products for the management of patients with or suspected of having sepsis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

Sponsored by
Philips Genomics

This webinar will provide an overview of how liquid biopsies can be integrated into lung cancer care.

Sponsored by

This webinar describes the characterization of gene fusions across distinct subtypes of melanoma.